Preston scientists have helped to develop an early test for prostate cancer.Advertisement
Researchers at the University of Central Lancashire have worked with a medical research company on the breakthrough to speed up screening for the disease.
Senior lecturer in clinical biochemistry Dr Carole Rolph said: “This is an exciting collaboration that genuinely has the potential to save lives.
“Cambridge Oncometrix is on the verge of developing a piece of kit that will dramatically speed up the diagnosis process for prostate cancer.
One in eight men in the UK will get prostate cancer and in the majority of cases it can be cured if caught in time.
Kevin Vardy, a terminal prostate cancer sufferer whose online campaign to introduce a national prostate screening programme attracted more than 50,000 signatures, has backed the research and is already working with UCLan pharmacy and biomedical sciences students through the University’s Comensus project which links services users with those training to work in health and social care.
Related: Watch Preston university uses 3D printer to print medicine capsule
The 53-year-old said: “Had this type of screening been around three years ago my cancer may have been treatable so anything that speeds up and simplifies the diagnosis process can only be positive.
“It’s great news that UCLan is helping Cambridge Oncometrix advance this technology; more than 40,000 men are diagnosed with prostate cancer every year and 11,000 will die from it so we need to bring this potentially life-saving research under the spotlight.”
Cambridge Oncometrix CEO Maxim Rossmann said: “Our long-term goal is to make our product widely available through the NHS and to do this it has to undergo an intense period of testing. Both UCLan and some of the hospitals in Lancashire will play a key role in this process. Most men go to the doctors with prostate problems when it’s too late and our simple accurate test can help to solve this problem.”
Worried about prostate cancer? You can get support and advice from Prostate Cancer UK